189 related articles for article (PubMed ID: 12912908)
1. Contrasting effects of VEGF gene disruption in embryonic stem cell-derived versus oncogene-induced tumors.
Viloria-Petit A; Miquerol L; Yu JL; Gertsenstein M; Sheehan C; May L; Henkin J; Lobe C; Nagy A; Kerbel RS; Rak J
EMBO J; 2003 Aug; 22(16):4091-102. PubMed ID: 12912908
[TBL] [Abstract][Full Text] [Related]
2. Oncogenes and Angiogenesis: down-regulation of thrombospondin-1 in normal fibroblasts exposed to factors from cancer cells harboring mutant ras.
Kalas W; Yu JL; Milsom C; Rosenfeld J; Benezra R; Bornstein P; Rak J
Cancer Res; 2005 Oct; 65(19):8878-86. PubMed ID: 16204059
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic ras fails to restore an in vivo tumorigenic phenotype in embryonic stem cells lacking vascular endothelial growth factor (VEGF).
Shi YP; Ferrara N
Biochem Biophys Res Commun; 1999 Jan; 254(2):480-3. PubMed ID: 9918864
[TBL] [Abstract][Full Text] [Related]
4. Rat embryo fibroblasts transformed by c-Jun display highly metastatic and angiogenic activities in vivo and deregulate gene expression of both angiogenic and antiangiogenic factors.
Kraemer M; Tournaire R; Dejong V; Montreau N; Briane D; Derbin C; Binétruy B
Cell Growth Differ; 1999 Mar; 10(3):193-200. PubMed ID: 10099833
[TBL] [Abstract][Full Text] [Related]
5. Tumor-derived expression of vascular endothelial growth factor is a critical factor in tumor expansion and vascular function.
Grunstein J; Roberts WG; Mathieu-Costello O; Hanahan D; Johnson RS
Cancer Res; 1999 Apr; 59(7):1592-8. PubMed ID: 10197634
[TBL] [Abstract][Full Text] [Related]
6. Adeno-associated virus vector-mediated delivery of pigment epithelium-derived factor restricts neuroblastoma angiogenesis and growth.
Streck CJ; Zhang Y; Zhou J; Ng C; Nathwani AC; Davidoff AM
J Pediatr Surg; 2005 Jan; 40(1):236-43. PubMed ID: 15868591
[TBL] [Abstract][Full Text] [Related]
7. The ratio of VEGF/PEDF expression in bone marrow mesenchymal stem cells regulates neovascularization.
Fan W; Crawford R; Xiao Y
Differentiation; 2011 Mar; 81(3):181-91. PubMed ID: 21236558
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of glioma invasion by overexpression of pigment epithelium-derived factor.
Guan M; Pang CP; Yam HF; Cheung KF; Liu WW; Lu Y
Cancer Gene Ther; 2004 May; 11(5):325-32. PubMed ID: 15044958
[TBL] [Abstract][Full Text] [Related]
9. The reduction in pigment epithelium-derived factor is a sign of malignancy in ovarian cancer expressing low-level of vascular endothelial growth factor.
Tsuchiya T; Nakahama K; Asakawa Y; Maemura T; Tanaka M; Takeda S; Morita M; Morita I
Gynecol Endocrinol; 2009 Feb; 25(2):104-9. PubMed ID: 19253105
[TBL] [Abstract][Full Text] [Related]
10. Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy.
Zhang SX; Wang JJ; Gao G; Parke K; Ma JX
J Mol Endocrinol; 2006 Aug; 37(1):1-12. PubMed ID: 16901919
[TBL] [Abstract][Full Text] [Related]
11. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of vascular endothelial growth factor and down-regulation of pigment epithelium-derived factor messenger ribonucleic acid levels in leptin-exposed cultured retinal pericytes.
Yamagishi S; Inagaki Y; Amano S; Okamoto T; Takeuchi M
Int J Tissue React; 2002; 24(4):137-42. PubMed ID: 12779248
[TBL] [Abstract][Full Text] [Related]
13. Chaotic neovascularization induced by aggressive fibrosarcoma cells overexpressing S-adenosylmethionine decarboxylase.
Paasinen-Sohns A; Kääriäinen E; Yin M; Järvinen K; Nummela P; Hölttä E
Int J Biochem Cell Biol; 2011 Mar; 43(3):441-54. PubMed ID: 21134486
[TBL] [Abstract][Full Text] [Related]
14. Pigment epithelium-derived factor acts as an opponent of growth-stimulatory factors in retinal glial-endothelial cell interactions.
Yafai Y; Lange J; Wiedemann P; Reichenbach A; Eichler W
Glia; 2007 Apr; 55(6):642-51. PubMed ID: 17309061
[TBL] [Abstract][Full Text] [Related]
15. Pigment epithelium-derived factor (PEDF)-induced apoptosis and inhibition of vascular endothelial growth factor (VEGF) expression in MG63 human osteosarcoma cells.
Takenaka K; Yamagishi S; Jinnouchi Y; Nakamura K; Matsui T; Imaizumi T
Life Sci; 2005 Nov; 77(25):3231-41. PubMed ID: 15985268
[TBL] [Abstract][Full Text] [Related]
16. Analysis of hypoxia-related gene expression in sarcomas and effect of hypoxia on RNA interference of vascular endothelial cell growth factor A.
Detwiller KY; Fernando NT; Segal NH; Ryeom SW; D'Amore PA; Yoon SS
Cancer Res; 2005 Jul; 65(13):5881-9. PubMed ID: 15994966
[TBL] [Abstract][Full Text] [Related]
17. Vitamin A up-regulates the expression of thrombospondin-1 and pigment epithelium-derived factor in retinal pigment epithelial cells.
Uchida H; Hayashi H; Kuroki M; Uno K; Yamada H; Yamashita Y; Tombran-Tink J; Kuroki M; Oshima K
Exp Eye Res; 2005 Jan; 80(1):23-30. PubMed ID: 15652522
[TBL] [Abstract][Full Text] [Related]
18. Pigment-epithelium-derived factor (PEDF) inhibits angiotensin-II-induced vascular endothelial growth factor (VEGF) expression in MOLT-3 T cells through anti-oxidative properties.
Yamagishi S; Matsui T; Nakamura K; Yoshida T; Shimizu K; Takegami Y; Shimizu T; Inoue H; Imaizumi T
Microvasc Res; 2006 May; 71(3):222-6. PubMed ID: 16624340
[TBL] [Abstract][Full Text] [Related]
19. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
Matsunaga N; Chikaraishi Y; Izuta H; Ogata N; Shimazawa M; Matsumura M; Hara H
Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666
[TBL] [Abstract][Full Text] [Related]
20. SiRNA-mediated inhibition of vascular endothelial growth factor severely limits tumor resistance to antiangiogenic thrombospondin-1 and slows tumor vascularization and growth.
Filleur S; Courtin A; Ait-Si-Ali S; Guglielmi J; Merle C; Harel-Bellan A; Clézardin P; Cabon F
Cancer Res; 2003 Jul; 63(14):3919-22. PubMed ID: 12873985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
